What does Respiro do?

Respiro is a specialist medical practice in Lennik. Private Limited, started on 17 October 2014, 1 establishment.

What is the address of Respiro?

The registered office of Respiro is located at Nellekenstraat 64, 1750 Lennik.

Is Respiro still active?

Yes. According to the CBE (30 October 2026) Respiro is active, legal situation “Normale toestand”, started on 17 October 2014.

Is Respiro registered on Peppol?

Yes, Respiro is registered on the Peppol network with ID 0208:0564819221.

What is the enterprise number of Respiro?

The enterprise number of Respiro is BE0564819221.

When was Respiro founded?

Respiro was founded on 17 October 2014.

Who are the directors of Respiro?

According to the 2025 annual accounts, the directors of Respiro are: Colin Cordemans.

Is Respiro a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 October 2014; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Respiro make in 2025?

Respiro posted a profit after taxes of € 428,177 in financial year 2025.

What is the revenue of Respiro?

As a small company, Respiro is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 511,680.

Respiro (Private Limited) - Lennik - BE0564819221

Dossier Respiro, printed on 30 October 2026 from databakkes.be/en/0564819221/respiro. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Respiro from Lennik, company number BE0564819221, closed financial year 2025 with a result of € 428,177 after tax. For that financial year Respiro recorded a gross margin of € 511,680 and equity of € 104,258. Compared with financial year 2024, the result moved from € 365,155 to € 428,177. Profitable, and profit is growing. The buffer shrank hard: equity is 80 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What it is worth Shrank hard

€ 104,258

▼ 80% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 428,177

▲ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 128,831

▼ 55% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 845,377 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,582

▲ 180% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,238

▲ 67% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 304,566 Gross margin 2022: € 304,566 First fiscal year in the series	€ 391,476 Gross margin 2023: € 391,476 ▲ 29% vs 2022 (€ 304,566) Favourable step	€ 516,624 Gross margin 2024: € 516,624 ▲ 32% vs 2023 (€ 391,476) Favourable step	€ 511,680 Gross margin 2025: € 511,680 ▼ 1% vs 2024 (€ 516,624) Unfavourable step	▼ 1%
Profit after taxes	€ 232,487 Profit after taxes 2022: € 232,487 First fiscal year in the series	€ 296,761 Profit after taxes 2023: € 296,761 ▲ 28% vs 2022 (€ 232,487) Favourable step	€ 365,155 Profit after taxes 2024: € 365,155 ▲ 23% vs 2023 (€ 296,761) Favourable step	€ 428,177 Profit after taxes 2025: € 428,177 ▲ 17% vs 2024 (€ 365,155) Favourable step	▲ 17%
Equity	€ 764,542 Equity 2022: € 764,542 First fiscal year in the series	€ 156,302 Equity 2023: € 156,302 ▼ 80% vs 2022 (€ 764,542) Unfavourable step	€ 521,458 Equity 2024: € 521,458 ▲ 234% vs 2023 (€ 156,302) Favourable step	€ 104,258 Equity 2025: € 104,258 ▼ 80% vs 2024 (€ 521,458) Unfavourable step	▼ 80%
Total debts	€ 27,231 Total debts 2022: € 27,231 First fiscal year in the series	€ 576,901 Total debts 2023: € 576,901 ▲ € 549,670 vs 2022 (€ 27,231) Unfavourable step	€ 8,191 Total debts 2024: € 8,191 ▼ 99% vs 2023 (€ 576,901) Favourable step	€ 253,771 Total debts 2025: € 253,771 ▲ € 245,579 vs 2024 (€ 8,191) Unfavourable step	▲ € 245,579
Cash	€ 495,789 Cash 2022: € 495,789 First fiscal year in the series	€ 294,756 Cash 2023: € 294,756 ▼ 41% vs 2022 (€ 495,789) Unfavourable step	€ 287,429 Cash 2024: € 287,429 ▼ 2% vs 2023 (€ 294,756) Unfavourable step	€ 128,831 Cash 2025: € 128,831 ▼ 55% vs 2024 (€ 287,429) Unfavourable step	▼ 55%
Retained profit	€ 745,992 Retained profit 2022: € 745,992 First fiscal year in the series	€ 137,752 Retained profit 2023: € 137,752 ▼ 82% vs 2022 (€ 745,992) Unfavourable step	€ 502,908 Retained profit 2024: € 502,908 ▲ 265% vs 2023 (€ 137,752) Favourable step	€ 85,708 Retained profit 2025: € 85,708 ▼ 83% vs 2024 (€ 502,908) Unfavourable step	▼ 83%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 905,000 Dividend 2023: € 905,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 905,000) Unchanged	€ 845,377 Dividend 2025: € 845,377 Unchanged (€ 0) Unchanged
Balance sheet total	€ 791,773 Balance sheet total 2022: € 791,773 First fiscal year in the series	€ 733,203 Balance sheet total 2023: € 733,203 ▼ 7% vs 2022 (€ 791,773) Unchanged	€ 529,649 Balance sheet total 2024: € 529,649 ▼ 28% vs 2023 (€ 733,203) Unchanged	€ 358,029 Balance sheet total 2025: € 358,029 ▼ 32% vs 2024 (€ 529,649) Unchanged	▼ 32%

Key figures of Respiro, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Respiro?

What happened at Respiro in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 428,177 (▲ 17% vs 2024). Source: NBB ↗
Oct 17, 2014 New establishment in Halle. KBO
Oct 17, 2014 Start of the company according to the CBE. KBO
2014 Colin Cordemans became a director. NBB

In short

From € 232,487 profit in 2022 to € 428,177 profit in 2025.

Paid € 403,996 in corporate taxes since 2022.

Best year ever: 2025, with € 428,177 profit.

Paid out € 1.8 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Colin Cordemans

Respiro

Behind Respiro is Colin Cordemans.

Directors

According to the 2025 annual accounts

Colin Cordemans

Director

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Nellekenstraat 64

1750 Lennik

2.237.078.237

Ziekenhuislaan 100

1500 Halle

Active since 17 October 2014

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0564.819.221

VAT number

BE 0564.819.221

Registered office

Nellekenstraat 64, 1750 Lennik

Names & denominations

Respiro

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 October 2014

Peppol

Active · Active since 25 Feb 2025

Activities · NACE

Activiteiten van medisch specialisten

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

Respiro

Financials

What happened to Respiro?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions